Valuation Caplin Point Laboratories Limited NSE India S.E.
Stocks
CAPLIPOINT
INE475E01026
Pharmaceuticals
|
Market Closed -
NSE India S.E.
07:05:07 2026-09-02 am EDT
|
5-day change | 1st Jan Change | ||
| 2,720.50 INR | +0.34% |
|
+10.06% | +48.01% |
| Aug. 14 | Caplin Point Laboratories Limited, Q1 2027 Earnings Call, Aug 12, 2026 | |
| Aug. 12 | Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Company Valuation: Caplin Point Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 30,571 | 51,529 | 45,291 | 100,038 | 152,221 | 206,349 | - | - |
| Change | - | 68.55% | -12.11% | 120.88% | 52.16% | 35.56% | - | - |
| Enterprise Value (EV) | 30,571 | 51,529 | 45,291 | 100,038 | 152,221 | 206,349 | 206,349 | 206,349 |
| Change | - | 68.55% | -12.11% | 120.88% | 52.16% | 35.56% | 0% | 0% |
| P/E | 12.7x | 17.3x | 12.1x | 22x | 28.5x | 17.9x | 28.4x | 24.5x |
| PBR | 2.58x | 3.47x | 2.41x | 4.32x | 5.34x | 3.19x | 4.67x | 4.22x |
| PEG | - | 0.7x | 0.5x | 1x | 1.6x | 0.9x | 1.6x | 1.6x |
| Capitalization / Revenue | 2.88x | 4.06x | 3.09x | 5.91x | 7.86x | 5.23x | 8.23x | 7.28x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 9.7x | 8.23x | 7.28x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 27.8x | 23.7x | 20.5x |
| EV / EBIT | 0x | 0x | 0x | - | 0x | 26.5x | 22.1x | 19.2x |
| EV / FCF | 0x | 0x | 0x | 0x | 0x | 54.3x | 37.1x | 36.6x |
| FCF Yield | 6.39% | 4.77% | 1.72% | 1.73% | 1.58% | 2.4% | 2.69% | 2.73% |
| Dividend per Share 2 | 3 | 2 | 2 | 2.5 | 3 | - | 4 | 4 |
| Rate of return | 0.74% | 0.29% | 0.34% | 0.19% | 0.15% | - | 0.15% | 0.15% |
| EPS 2 | 31.71 | 39.26 | 49.18 | 59.9 | 70.25 | 84.11 | 95.6 | 110.7 |
| Distribution rate | 9.46% | 5.09% | 4.07% | 4.17% | 4.27% | - | 4.18% | 3.61% |
| Net sales 1 | 10,613 | 12,694 | 14,667 | 16,941 | 19,375 | 21,872 | 25,072 | 28,340 |
| EBITDA 1 | 3,286 | 3,947 | 4,411 | 5,514 | 6,469 | 7,609 | 8,700 | 10,050 |
| EBIT 1 | 3,152 | 3,478 | 4,520 | - | 5,810 | 8,036 | 9,321 | 10,752 |
| Net income 1 | 2,423 | 2,998 | 3,763 | 4,571 | 5,363 | 6,412 | 7,264 | 8,411 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 404.15 | 679.90 | 596.70 | 1,317.30 | 2,002.60 | 2,710.95 | 2,710.95 | 2,710.95 |
| Nbr of stocks (in thousands) | 75,643 | 75,789 | 75,903 | 75,942 | 76,012 | 76,012 | - | - |
| Announcement Date | 5/6/21 | 5/12/22 | 5/27/23 | 5/16/24 | 5/15/25 | 5/14/26 | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 35.59x | 6.69x | 23.19x | 0.89% | 48.77B | |
| 17.84x | 2.24x | 10.09x | 1.45% | 40.67B | |
| 28x | 3.99x | 16.54x | 0.58% | 12.27B | |
| 27.7x | 3.37x | 17.45x | 0.91% | 12.11B | |
| 19.06x | 3.39x | 11.8x | 3.78% | 9.28B | |
| 9.6x | 2.21x | 5.72x | 4.51% | 7.55B | |
| 30.05x | 3.93x | 18.3x | 0.15% | 7.35B | |
| 16.03x | 2.11x | 6.82x | 3.15% | 7.3B | |
| Average | 22.98x | 3.49x | 13.74x | 1.93% | 18.16B | |
| Weighted average by Cap. | 25.65x | 4.13x | 15.78x | 1.47% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CAPLIPOINT Stock
- CAPLIPOINT Stock
- Valuation Caplin Point Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
